| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |